Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Dose-Intensification Study Using Radiation Therapy and Concurrent Cisplatin and Etoposide for Patients With Inoperable Non-small Cell Lung Cancer

NCT01411098 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01411098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01411098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Dose-Intensification Study Using Radiation Therapy and Concurrent Cisplatin and Etoposide for Patients With Inoperable Non-small Cell Lung Cancer
Lead sponsor
University of Washington
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 2011
Completion date
Not reported
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent non-small cell lung cancer, stage iib non-small cell lung cancer, stage iiia non-small cell lung cancer, stage iiib non-small cell lung cancer